Page last updated: 2024-10-28

hexamethonium and Hypovolemic

hexamethonium has been researched along with Hypovolemic in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palheta, RC1
Silva, MT1
Barbosa, HL1
Pinheiro, AD1
Cardoso, KV1
Graça, JR1
Magalhães, PJ1
Oliveira, RB1
Santos, AA1

Other Studies

1 other study available for hexamethonium and Hypovolemic

ArticleYear
Atrial stretch delays gastric emptying of liquids in awake rats.
    Life sciences, 2013, Mar-21, Volume: 92, Issue:10

    Topics: Analysis of Variance; Animals; Atrial Function, Right; Atropine; Balloon Occlusion; Blood Pressure;

2013